Guides the vision and growth of GFMD. With a distinguished career as a nurse and clinical psychologist, she is the creator and intellectual designer of the foundation's research model and its evaluation instruments on the KoboToolbox platform. Driven by a deep empathy for the pain, isolation, and invisible suffering experienced by patients with metabolic conditions like TMAU, she has successfully structured an international database for the first time. Her work blends social sensitivity and psychological support with scientific research, focusing on bringing visibility to this condition within the medical community and restoring hope and deeply compassionate care to each patient and their families.

Serves as the vital scientific advisor guiding the microbiome and metabolic disease research initiatives at GFMD. As a world-class leader in cellular microbiology and the founder of BioMe™, Dr. Yoon has been instrumental in uncovering how gut microbes and their metabolites regulate key metabolic pathways. His research bridges cutting-edge microbiome insights with targeted therapeutic development, driving strategic global collaborations to find definitive treatments and clinical solutions for metabolic patients worldwide.

Currently completing her final year of medical school and serves as the scientific force driving data collection and analysis at GFMD. As an expert in utilizing global monitoring systems like KoboToolbox, she has been instrumental in consolidating the most robust patient database in the region. Her work ensures that the patient's voice is translated into rigorous scientific evidence, facilitating strategic alliances with world-class researchers to find treatments and definitive solutions.

Leads the legal structure, regulatory compliance, and rights protection at GFMD. Her management is fundamental to consolidating the foundation's legal framework, ensuring operations meet the highest international standards. Additionally, she builds institutional bridges, ensuring that the voice and needs of the TMAU patient community are legally secured and rigorously represented before global public and scientific organizations.

Software Engineer and a prominent advocate for the rights of patients with metabolic conditions in the United States. At GFMD, he leads the international expansion and liaison strategy from North America. His technical expertise and community management experience are key to connecting the foundation with global support networks, international agencies, and technological advancements that drive visibility and solutions for the organization.